Edward Tenthoff
Sr Research Analyst
Research
Sector Expertise
Additional Expertise
Biotechnology
Ted Tenthoff is a managing director and senior research analyst at Piper Sandler, focused on the drug discovery sector of the biotech industry. In April 2013 and 2015, Tenthoff moderated panels at the International Adult Stem Cell Conference at the Vatican. He was ranked No. 2 stock picker in biotechnology by the 2012 Wall Street Journal "Best on the Street" survey and was ranked No. 1 stock picker for the life science tools and services sector in the 2006 Starmine Analyst Awards. Prior to joining Piper Sandler in 2003, he covered the genomics sector at Robertson Stephens & Company, and was a medical technology analyst at Lehman Brothers. Tenthoff received a bachelor’s degree in international relations from the University of Pennsylvania.
Universe Coverage
Biotechnology | |
---|---|
ALNY | Alnylam Pharmaceuticals, Inc. |
ARWR | Arrowhead Pharmaceuticals |
ARVN | Arvinas Inc. |
CAMP | CAMP4 Therapeutics Corporation |
CAPR | Capricor Therapeutics, Inc. |
IPSC | Century Therapeutics, Inc. |
CRSP | CRISPR Therapeutics AG |
CUE | Cue Biopharma, Inc. |
DYN | Dyne Therapeutics, Inc. |
FATE | Fate Therapeutics, Inc. |
FULC | Fulcrum Therapeutics, Inc. |
KYMR | Kymera Therapeutics, Inc. |
LEGN | Legend Biotech Corporation |
MESO | Mesoblast Ltd. |
MIST | Milestone Pharmaceuticals, Inc. |
MRNA | Moderna, Inc. |
GLUE | Monte Rosa Therapeutics, Inc. |
NXTC | NextCure, Inc. |
OMGA | Omega Therapeutics, Inc. |
OPK | OPKO Health, Inc. |
PSTX | Poseida Therapeutics, Inc. |
MCRB | Seres Therapeutics, Inc. |
SKYE | Skye Bioscience, Inc. |
STRO | Sutro Biopharma, Inc. |
SYRS | Syros Pharmaceuticals, Inc. |
TPST | Tempest Therapeutics, Inc. |
XFOR | X4 Pharmaceuticals, Inc. |
XNCR | Xencor, Inc. |